Ewa R.
- Country
- Germany
- Department
- Onkologische Zentren Onkomedeor
Research Overview
Data & Insights
Has run more than one trial at 0 of 23 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in the treatment and research of multiple myeloma, focusing on developing innovative therapeutic strategies for this hematologic malignancy.
- Disease Response Assessment
- Treatment Stratification
- Clinical Outcomes Evaluation
Expertise includes evaluation of minimal residual disease detection methods and implementation of advanced diagnostic techniques including flow cytometry and next-generation sequencing.
Personalized Medicine
Primary focus on developing expression-linked strategies for treatment optimization in hematologic malignancies, with particular attention to first-line therapy adaptation.
- Biomarker-Based Treatment
- Risk Stratification
- Treatment Response Monitoring
Specializes in implementing adaptive treatment approaches based on molecular and clinical parameters.
Clinical Standards Development
Active involvement in establishing treatment protocols according to International Myeloma Working Group (IMWG) criteria, with emphasis on standardized response assessment.
- Treatment Guidelines
- Response Criteria Development
- Clinical Practice Standards
Focuses on integrating modern diagnostic techniques with established clinical parameters for optimal patient care.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
